Chosa Oncology Investor Relations Material
Latest events
Investor Update
Chosa Oncology
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Chosa Oncology
Access all reports
Chosa Oncology AB is a Sweden-based biotechnology company focused on the development of innovative cancer therapies. The company specializes in identifying and advancing novel treatment options targeting unmet medical needs in oncology. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
CHOSA
Country
🇸🇪 Sweden